Atuss
NDC Package 15370-140-04

11-digit billing NDC: 15370014004

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atuss is a . Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-140 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
15370-140-04
Package Description
118 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
15370014004

Clinical Specifications

Proprietary Name
Atuss DA
Dosage Form
-

Regulatory & Marketing

Labeler Name
Carwin Pharmaceutical Associates, Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-25-2016
End Marketing Date
01-16-2023
Listing Expiration
01-16-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (15370-140). Click a package code to view its specific billing and regulatory data.

473 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15370-140-04 identifies a specific commercial package of 118 ml in 1 bottle, plastic of Atuss DA, labeled by Carwin Pharmaceutical Associates, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on October 25, 2016. The current certification is valid through January 16, 2023.

How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370014004. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
15370-140-04
11-Digit CMS (5-4-2)
15370-0140-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.